| For: | Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(36): 8112-8122 [PMID: 27688653 DOI: 10.3748/wjg.v22.i36.8112] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i36/8112.htm |
| Number | Citing Articles |
| 1 |
Tatiana Kisseleva, Souradipta Ganguly, Rabi Murad, Allen Wang, David A. Brenner. Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction–Associated Steatohepatitis. Gastroenterology 2025; 169(5) doi: 10.1053/j.gastro.2025.03.010
|
| 2 |
Evaluation of hepcidin and its relationship with iron in non-alcoholic fatty liver disease. Biomedicine 2022; 42(1) doi: 10.51248/.v42i1.680
|
| 3 |
Sandra Maria Barbalho, Lucas Fornari Laurindo, Ricardo José Tofano, Uri Adrian Prync Flato, Claudemir G. Mendes, Ricardo de Alvares Goulart, Ana Maria Gonçalves Milla Briguezi, Marcelo Dib Bechara. Dysmetabolic Iron Overload Syndrome: Going beyond the Traditional Risk Factors Associated with Metabolic Syndrome. Endocrines 2023; 4(1) doi: 10.3390/endocrines4010002
|
| 4 |
Anne Kaul, Annette Masuch, Kathrin Budde, Gabi Kastenmüller, Anna Artati, Jerzy Adamski, Henry Völzke, Matthias Nauck, Nele Friedrich, Maik Pietzner. Molecular Fingerprints of Iron Parameters among a Population-Based Sample. Nutrients 2018; 10(11) doi: 10.3390/nu10111800
|
| 5 |
T. Antofiichuk, O. Khukhlina, M. Antofiichuk, N. Kaspruk. Metabolic preconditions for the formation andprogression of steatohepatitis of alcoholic,mixed, non-alcoholic aetiology and their comorbidity withobesity and anaemic conditions. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2023; 19(3) doi: 10.22141/2224-0721.19.3.2023.1267
|
| 6 |
Matthew T. Goodus, Kaitlin E. Carson, Andrew D. Sauerbeck, Priyankar Dey, Anthony N. Alfredo, Phillip G. Popovich, Richard S. Bruno, Dana M. McTigue. Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits. Experimental Neurology 2021; 342 doi: 10.1016/j.expneurol.2021.113725
|
| 7 |
Hye Young Kim, Chul Hee Park, Joon Beom Park, Kangeun Ko, Mi Hwa Lee, Jin Chung, Young Hyun Yoo. Hepatic STAMP2 alleviates polychlorinated biphenyl‐induced steatosis and hepatic iron overload in NAFLD models. Environmental Toxicology 2022; 37(9) doi: 10.1002/tox.23589
|
| 8 |
Marià Alemany. The Metabolic Syndrome, a Human Disease. International Journal of Molecular Sciences 2024; 25(4) doi: 10.3390/ijms25042251
|
| 9 |
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(1) doi: 10.1016/j.jcmgh.2021.01.019
|
| 10 |
Sana Raza, Archana Tewari, Sangam Rajak, Pratima Gupta, Rohit A. Sinha. Extracellular RNA mediates iron-induced toxicity and inflammatory signalling in hepatic cells. Toxicology Reports 2025; 14 doi: 10.1016/j.toxrep.2025.102002
|
| 11 |
Hana’a Mahmoud Al-Dayyat, Yaser Mohammed Rayyan, Reema Fayez Tayyem. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(4) doi: 10.1016/j.dsx.2018.03.016
|
| 12 |
Jacek Baj, Beata Kowalska, Aleksandra Barbachowska, Alicja Forma, Michał Flieger, Dariusz Majerek, Grzegorz Teresiński, Wojciech Flieger, Piero Portincasa, Grzegorz Buszewicz, Elżbieta Radzikowska-Büchner, Jolanta Flieger. Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease—Postmortem ICP-MS Analysis of Selected Human Tissues. Nutrients 2023; 15(15) doi: 10.3390/nu15153458
|
| 13 |
Sofía Montemayor, Silvia García, Margalida Monserrat-Mesquida, Josep A. Tur, Cristina Bouzas. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients 2023; 15(18) doi: 10.3390/nu15183987
|
| 14 |
Cenqin Liu, Yishu Chen, Zhixin Zhang, Jiarong Xie, Chaohui Yu, Lei Xu, Youming Li. Iron Status and NAFLD among European Populations: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients 2022; 14(24) doi: 10.3390/nu14245237
|
| 15 |
Renee Hernandez, Natasha S. Garcia-Rodriguez, Marco A. Arriaga, Ricardo Perez, Auwal A. Bala, Ana C. Leandro, Vince P. Diego, Marcio Almeida, Jason G. Parsons, Eron G. Manusov, Jacob A. Galan. The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1513598
|
| 16 |
Zewen Sun, Xingchen Pan, Aowen Tian, Ida Surakka, Tao Wang, Xu Jiao, Shanshan He, Jinfang Song, Xin Tian, Dan Tong, Jianping Wen, Yonggang Zhang, Wanqing Liu, Peng Chen. Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals. JHEP Reports 2023; 5(7) doi: 10.1016/j.jhepr.2023.100744
|
| 17 |
Yan-Hang Gao, Jing-Yun Wang, Pei-Yan Liu, Jing Sun, Xiao-Mei Wang, Rui-Hong Wu, Xiu-Ting He, Zheng-Kun Tu, Chun-Guang Wang, Hong-Qin Xu, Jun-Qi Niu. Iron metabolism disorders in patients with hepatitis B-related liver diseases. World Journal of Clinical Cases 2018; 6(13): 600-610 doi: 10.12998/wjcc.v6.i13.600
|
| 18 |
Fang Zhong, Liying Guan, Haiyan Lin, Meng Zhao, Yiming Qin, Qihang Li, Zhongshang Yuan, Guang Yang, Ling Gao, Jiajun Zhao. Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.760981
|
| 19 |
Noémie Le Tallec-Estève, Chloé Rousseau, Benoit Desrues, Olivier Loréal, Ronan Thibault. Transferrin saturation is independently associated with the severity of obstructive sleep apnea syndrome and hypoxia among obese subjects. Clinical Nutrition 2021; 40(2) doi: 10.1016/j.clnu.2020.06.007
|
| 20 |
Hye Young Kim, Woo Young Kwon, Joon Beom Park, Mi Hwa Lee, Yoo Jin Oh, SungHwan Suh, Yang Hyun Baek, Jin Sook Jeong, Young Hyun Yoo. Hepatic STAMP2 mediates recombinant FGF21‐induced improvement of hepatic iron overload in nonalcoholic fatty liver disease. The FASEB Journal 2020; 34(9) doi: 10.1096/fj.202000790R
|
| 21 |
Hong Lu. Inflammatory liver diseases and susceptibility to sepsis. Clinical Science 2024; 138(7) doi: 10.1042/CS20230522
|
| 22 |
. 2019; doi: 10.70675/2c39bb73z8509z4902z9e40ze0b995ba218b
|
| 23 |
Marwa Matboli, Manar Fouad Ahmed, Amany Helmy Hasanin, Reham Hussein Mohamed, Eman H. Eltantawy, Ghada Galal Hamam, Marwa Ramadan M. Abdelhalim, Maryam Elmasry, Marwa M. El-Shafei, Shaimaa Hamady. Amlodipine and perindopril modulate miR-874-3p expression to regulate ferroptosis-linked LPCAT3/LACS4/GPX4 Axis and gut dysbiosis in metabolic-associated steatohepatitis. International Immunopharmacology 2025; 164 doi: 10.1016/j.intimp.2025.115333
|
| 24 |
Gong Feng, Christopher D. Byrne, Giovanni Targher, Fudi Wang, Ming‐Hua Zheng. Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link?. Liver International 2022; 42(7) doi: 10.1111/liv.15163
|
| 25 |
Jihye Kim, Hye Won Woo, Min-Ho Shin, Yu-Mi Kim, Ji Eun Lim, Bermseok Oh, Dae Sub Song, Insong Koh, Mi Kyung Kim. Genome-wide gene and serum ferritin interaction in the development of type 2 diabetes in adults aged 40 years or older. Nutrition, Metabolism and Cardiovascular Diseases 2022; 32(1) doi: 10.1016/j.numecd.2021.09.028
|
| 26 |
Meilin Zhu, Hanqing Chen, Shuang Zhou, Lingna Zheng, Xue Li, Runxuan Chu, Wei Chen, Bing Wang, Meng Wang, Zhifang Chai, Weiyue Feng. Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload. Nanotoxicology 2021; 15(6) doi: 10.1080/17435390.2021.1919329
|
| 27 |
Ulrike Schmidt, Betül Uluca, Iva Vokic, Barizah Malik, Thomas Kolbe, Caroline Lassnig, Martin Holcmann, Veronica Moreno-Viedma, Bernhard Robl, Carina Mühlberger, Dagmar Gotthardt, Maria Sibilia, Thomas Rülicke, Mathias Müller, Agnes Csiszar, Michael Klymkowsky. Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice. PLOS ONE 2023; 18(9) doi: 10.1371/journal.pone.0286256
|
| 28 |
Chenhui Ma, Li Han, Zheying Zhu, Cheng Heng Pang, Guoyu Pan. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochemical Pharmacology 2022; 205 doi: 10.1016/j.bcp.2022.115242
|
| 29 |
Lanling Xiao, Rui Tang, Jie Wang, Dan Wan, Yulong Yin, Liwei Xie. Gut microbiota bridges the iron homeostasis and host health. Science China Life Sciences 2023; 66(9) doi: 10.1007/s11427-022-2302-5
|
| 30 |
Eleni Asprouli, Ioanna Panagiota Kalafati, Aikaterini Sakellari, Sotirios Karavoltsos, John Vlachogiannakos, Konstantinos Revenas, Alexander Kokkinos, Manos Dassenakis, George V. Dedoussis, Nick Kalogeropoulos. Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease. Biological Trace Element Research 2019; 188(2) doi: 10.1007/s12011-018-1432-9
|
| 31 |
Clémence Rives, Anne Fougerat, Sandrine Ellero-Simatos, Nicolas Loiseau, Hervé Guillou, Laurence Gamet-Payrastre, Walter Wahli. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020; 10(12) doi: 10.3390/biom10121702
|
| 32 |
He Zhou, Tong Wu, Zhenzhen Fan, Yanting Shi, Fang Wang, Jindan He, Yu Da, Junchao Lin, Jiaqi Zhang, Jie Liang. Dietary iron imbalance disrupts enterohepatic homeostasis via the gut microbiota–bile acid–FXR signaling axis. The Journal of Nutritional Biochemistry 2026; doi: 10.1016/j.jnutbio.2026.110508
|
| 33 |
Duraid Jaffar Tauma, Ammar Lateef Huseein, Abdolamir Allameh. Changes in Circulating Endoplasmic Reticulum to Nucleus Signaling 1 (ERN1) and Hepcidin in Patients with Iron Overload and MASH Diseases. Indian Journal of Clinical Biochemistry 2025; doi: 10.1007/s12291-025-01375-4
|
| 34 |
Dana Kaldarkhan, Gulnaz Nuskabayeva, Nursultan Nurdinov, Ugilzhan Tatykayeva, Ainash Oshibayeva, Shoira Isanova, Arzu Mamutova, Yusuf Ozkul, Nuriye Gokce, Izem Olcay Sahin, Karlygash Sadykova. Functional Iron-Transport Genes—TF and TMPRSS6—As Genetic Determinants of Transferrin and Fasting Glucose in a Kazakh Adult Cohort: A Whole-Exome Sequencing Pilot Study. International Journal of Molecular Sciences 2026; 27(12) doi: 10.3390/ijms27125374
|
| 35 |
Jagadish Ramasamy. Diagnostic Utility of Serum Ferritin in Identifying Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Cross-Sectional Study Using National Health and Nutrition Examination Survey (NHANES—2017–2020) Data. Indian Journal of Clinical Biochemistry 2025; 40(1) doi: 10.1007/s12291-023-01159-8
|
| 36 |
Yves Deugnier, Édouard Bardou-Jacquet, Fabrice Lainé. Dysmetabolic iron overload syndrome (DIOS). La Presse Médicale 2017; 46(12) doi: 10.1016/j.lpm.2017.05.036
|
| 37 |
Jule Filler, Ricarda von Krüchten, Nina Wawro, Lisa Maier, Roberto Lorbeer, Johanna Nattenmüller, Barbara Thorand, Fabian Bamberg, Annette Peters, Christopher L. Schlett, Jakob Linseisen, Susanne Rospleszcz. Association of Habitual Dietary Intake with Liver Iron—A Population-Based Imaging Study. Nutrients 2021; 14(1) doi: 10.3390/nu14010132
|
| 38 |
Xiaoyu Feng, Wenfeng Hu, Yujiao Hong, Linlin Ruan, Yueben Hu, Dan Liu, Zhihao Jia. [Retracted] Taurine Ameliorates Iron Overload‐Induced Hepatocyte Injury via the Bcl‐2/VDAC1‐Mediated Mitochondrial Apoptosis Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/4135752
|
| 39 |
Lin Xiao, Gang Luo, Hongxia Li, Ping Yao, Yuhan Tang. Dietary iron overload mitigates atherosclerosis in high-fat diet-fed apolipoprotein E knockout mice: Role of dysregulated hepatic fatty acid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(10) doi: 10.1016/j.bbalip.2021.159004
|
| 40 |
Franciele Sabadin Bertol, Bruna Araujo, Brunno Brochado Jorge, Natalino Rinaldi, Luiz Alberto De Carli, Cristiane Valle Tovo. Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. World Journal of Gastrointestinal Surgery 2020; 12(6): 269-276 doi: 10.4240/wjgs.v12.i6.269
|
| 41 |
Hye Young Kim, Young Hyun Yoo. The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A Review. Biomedicines 2022; 10(9) doi: 10.3390/biomedicines10092082
|
| 42 |
Nikolaos-Andreas T. Anastasopoulos, Georgios D. Lianos, Vera Tatsi, Anastasia Karampa, Anna Goussia, Georgios K. Glantzounis. Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(11) doi: 10.1080/17474124.2020.1802244
|
| 43 |
Yang Wang, Bugao Zhou, Shanshan Li, Linxin Zheng, Xiongfeng Huang, Huiyu Wang, Sili Li, Yuhan Lin, Yanhe Xu. SLC11A1 protein as a key regulator of iron metabolism, ferroptosis mediator, and putative therapeutic target in nonalcoholic fatty liver disease: an integrated bioinformatics analysis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1715699
|
| 44 |
Gang Luo, Lu Xiang, Lin Xiao. Iron Restriction Alleviates Atherosclerosis in ApoE KO Mice: An iTRAQ Proteomic Analysis. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232415915
|
| 45 |
Fengping Yao, Xiaohong Cui, Ying Zhang, Zhuchun Bei, Hongquan Wang, Dongxu Zhao, Hong Wang, Yongfei Yang. Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma. Oncology Letters 2021; 22(3) doi: 10.3892/ol.2021.12918
|
| 46 |
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?. Experimental Neurology 2020; 325 doi: 10.1016/j.expneurol.2019.113160
|
| 47 |
Yun Lai, Fen fen Gao, Ruo ting Ge, Rui Liu, Shumei Ma, Xiaodong Liu. Metal ions overloading and cell death. Cell Biology and Toxicology 2024; 40(1) doi: 10.1007/s10565-024-09910-4
|
| 48 |
Hsuan-Hui Wang, Li-Na Liao, Ci-Wen Chang, Yu-Chang Chang, Kang-Hsi Wu, Jiunn-Liang Ko. The alteration of ferritin and transferrin saturation under body mass index and blood pressure in first-time and regular male blood donors in Taiwan. Medicine 2019; 98(22) doi: 10.1097/MD.0000000000015854
|
| 49 |
Ryan L. Gonciarz, Eric A. Collisson, Adam R. Renslo. Ferrous Iron-Dependent Pharmacology. Trends in Pharmacological Sciences 2021; 42(1) doi: 10.1016/j.tips.2020.11.003
|
| 50 |
Xiangyong Hao, Hao Song, Xin Su, Jian Li, Youbao Ye, Cailiu Wang, Xiao Xu, Guanglong Pang, Wenxiu Liu, Zihan Li, Tian Luo. Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2025.2464223
|
| 51 |
Zhengyu Hu, Yan Li, Bingwei Ma, Saifei Lei, Xingchun Wang. Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.952056
|
| 52 |
Qi Song, Junxia Guo, Yanzhen Zhang, Wen Chen. The beneficial effects of taurine in alleviating fatty liver disease. Journal of Functional Foods 2021; 77 doi: 10.1016/j.jff.2020.104351
|
| 53 |
Yali Li, Dan Jin, Suwei Liu, Chenyu Jiang, Ming Ni, Limin Feng, Yan Zhang, Yuxin Yang, Guangjin Zhou, Jiajia Xu, Shipei He, Liqiang Zhou, Huishu Yuan. Quantification of the Proton Density Fat Fraction and Iron Content: A Comparative Study Between 3.0 T and 5.0 T MRI. Journal of Magnetic Resonance Imaging 2025; 62(2) doi: 10.1002/jmri.29743
|
| 54 |
Ashok Mandala, William J. Chen, Austin Armstrong, Milan R. Malhotra, Sanmathi Chavalmane, Kyle S. McCommis, Anping Chen, Danielle Carpenter, Pratim Biswas, Jaya P. Gnana-Prakasam. PPARα agonist fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and β-catenin signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 321(3) doi: 10.1152/ajpgi.00129.2021
|
| 55 |
Ziping Song, Xinlei Miao, Xiaoling Xie, Guimin Tang, Jiayi Deng, Manling Hu, Shuang Liu, Song Leng. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02129-6
|
| 56 |
A. Yasmin Syauki, Aki Ogawa, Uli Rina Pelegia Simanjuntak, Ingrid Gloria Mangiwa, Miki Doi, Suzumi Kageyama, Rikako Inoue, Nurpudji A. Taslim, Yasuyuki Irie. Protein-Energy Nutritional Status of Moderately Low Protein Intake-Sago Diets Compared to Sufficiently Protein Intake-Rice Diets in Well-Nourished Lowlanders in Papua, Indonesia. F1000Research 2022; 11 doi: 10.12688/f1000research.76099.1
|
| 57 |
Leonardo dos Santos, Sabrina Rodrigues Bertoli, Renata Andrade Ávila, Vinícius Bermond Marques. Iron overload, oxidative stress and vascular dysfunction: Evidences from clinical studies and animal models. Biochimica et Biophysica Acta (BBA) - General Subjects 2022; 1866(9) doi: 10.1016/j.bbagen.2022.130172
|
| 58 |
Huanjia Qu, Lingling Zhou, Jing Wang, Dong Tang, Qiuling Zhang, Junping Shi. Iron overload is closely associated with metabolic dysfunction‐associated fatty liver disease in type 2 diabetes. Obesity 2025; 33(3) doi: 10.1002/oby.24236
|
| 59 |
Mahider Shimelis Feyisa, Sintayehu Ambachew, Alemie Fentie Mebratie, Bruktawit Eshetu Ali, Rishan Hadgu Asefa, Elias Chane Asefa, Mahder Girma Asmamaw, Getnet Fetene. Nonalcoholic Fatty Liver Disease Status and Its Associated Factors Among Patients With Type 2 Diabetes Mellitus in Adama Hospital Medical College, South Eastern Ethiopia: A Cross‐Sectional Study. Health Science Reports 2026; 9(2) doi: 10.1002/hsr2.71773
|
| 60 |
Anna M. Hoy, Natasha McDonald, Ross J. Lennen, Matteo Milanesi, Amy H. Herlihy, Timothy J. Kendall, William Mungall, Michael Gyngell, Rajarshi Banerjee, Robert L. Janiczek, Philip S. Murphy, Maurits A. Jansen, Jonathan A. Fallowfield. Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biology Open 2018; 7(7) doi: 10.1242/bio.033910
|
| 61 |
Qi Sheng, Shousheng Liu, Haiyang Yu, Huanchen Shi, Yongning Xin. The association of dietary nutrients consumption with hepatic steatosis and fibrosis from NHANES 2017–2020. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1510860
|
| 62 |
James A. Rioux, Miriam Hewlett, Christa Davis, Chris V. Bowen, Kimberly Brewer, Sharon E. Clarke, Steven D. Beyea. Mapping of fatty acid composition with free‐breathing MR spectroscopic imaging and compressed sensing. NMR in Biomedicine 2021; 34(5) doi: 10.1002/nbm.4241
|
| 63 |
|
| 64 |
Monique Fernandez, Julie Lokan, Christopher Leung, Andrew Grigg. A critical evaluation of the role of iron overload in fatty liver disease. Journal of Gastroenterology and Hepatology 2022; 37(10) doi: 10.1111/jgh.15971
|
| 65 |
Matthew T. Goodus, Andrew D. Sauerbeck, Phillip G. Popovich, Richard S. Bruno, Dana M. McTigue. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but Does Not Improve Chronic Hepatic and Spinal Cord Pathology in Rats. Journal of Neurotrauma 2018; 35(24) doi: 10.1089/neu.2018.5771
|
| 66 |
Junzhao Ye, Ting Feng, Lei Su, Jin Li, Yingying Gong, Xiaoyi Ma. Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review. Helicobacter 2023; 28(6) doi: 10.1111/hel.13030
|
| 67 |
Jingyi Jin, Yue Li, Furong Qiu, Dongming Yan. Ferroptosis in metabolic dysfunction-associated steatotic liver disease: Molecular mechanisms and therapeutic potential of traditional Chinese medicine–a systematic review of preclinical studies. Pharmacological Research - Modern Chinese Medicine 2026; 20 doi: 10.1016/j.prmcm.2026.100857
|
| 68 |
Hong Gao, Zhongmou Jin, Gautam Bandyopadhyay, Gaowei Wang, Dinghong Zhang, Karina Cunha e Rocha, Xiao Liu, Huayi Zhao, Tatiana Kisseleva, David A. Brenner, Michael Karin, Wei Ying. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metabolism 2022; 34(8) doi: 10.1016/j.cmet.2022.07.006
|
| 69 |
Giuseppina Palladini, Laura Giuseppina Di Pasqua, Marta Cagna, Anna Cleta Croce, Stefano Perlini, Barbara Mannucci, Antonella Profumo, Andrea Ferrigno, Mariapia Vairetti. MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis. International Journal of Molecular Sciences 2022; 23(12) doi: 10.3390/ijms23126817
|
| 70 |
Sophie Gensluckner, Bernhard Wernly, Florian Koutny, Georg Strebinger, Stephan Zandanell, Lars Stechemesser, Bernhard Paulweber, Bernhard Iglseder, Eugen Trinka, Vanessa Frey, Patrick Langthaler, Georg Semmler, Luca Valenti, Elena Corradini, Christian Datz, Elmar Aigner. Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort. Biomedicines 2024; 12(1) doi: 10.3390/biomedicines12010207
|
| 71 |
Genfeng Yu, Lan Liu, Tao Qin, Yaosheng Luo, Cheng Song, Xingying Chen, Hualin Duan, Yuqi Jiang, Huixian Zeng, Heng Wan, Jie Shen. Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study. Biological Trace Element Research 2024; 202(1) doi: 10.1007/s12011-023-03666-4
|
| 72 |
Giuseppina Palladini, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Chen Ling. Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease. PLOS ONE 2020; 15(12) doi: 10.1371/journal.pone.0243179
|
| 73 |
Caroline C. Philpott, Olga Protchenko, Yubo Wang, Lorena Novoa-Aponte, Andres Leon-Torres, Samantha Grounds, Amber J. Tietgens. Iron-tracking strategies: Chaperones capture iron in the cytosolic labile iron pool. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1127690
|
| 74 |
Liao Tan, Qiaoyu Zhou, Jie Liu, Zhaoya Liu, Ruizheng Shi. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017–2018. Food & Function 2023; 14(12) doi: 10.1039/D2FO04082D
|
| 75 |
Cristina Galarregui, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Víctor de la O, Miguel Ruiz-Canela, Helen Hermana M. Hermsdorff, Josefina Bressan, Josep A. Tur, J. Alfredo Martínez, M. Angeles Zulet, Itziar Abete. Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study. European Journal of Nutrition 2021; 60(4) doi: 10.1007/s00394-020-02370-6
|
| 76 |
Jun-Wei Wang, Chun-Hua Jin, Jiang-Feng Ke, Yi-Lin Ma, Yu-Jie Wang, Jun-Xi Lu, Mei-Fang Li, Lian-Xi Li. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.942412
|
| 77 |
Hanqing Chen. Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target. Liver Research 2022; 6(4) doi: 10.1016/j.livres.2022.09.003
|
| 78 |
Kaitlin Day, Lucia A. Seale, Ross M. Graham, Barbara R. Cardoso. Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.744825
|
| 79 |
John Wagner, Carine Fillebeen, Tina Haliotis, Edouard Charlebois, Angeliki Katsarou, Jeannie Mui, Hojatollah Vali, Kostas Pantopoulos, Fanis Missirlis. Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet. PLOS ONE 2019; 14(8) doi: 10.1371/journal.pone.0221455
|
| 80 |
Dina G. Tiniakos, Stratigoula Sakellariou. Non-Alcoholic Fatty Liver Disease. 2020; doi: 10.1007/978-3-319-95828-6_3
|
| 81 |
Stuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, Lynsey Corless, Quentin M Anstee, Richard J Aspinall, Stephen T Barclay, Paul N Brennan, Tessa M Cacciottolo, Robert D Goldin, Kate Hallsworth, Vanessa Hebditch, Kathryn Jack, Helen Jarvis, Jill Johnson, Wenhao Li, Dina Mansour, Mary McCallum, Ashis Mukhopadhya, Richard Parker, Valerie Ross, Ian A Rowe, Ankur Srivastava, Prarthana Thiagarajan, Alexandra I Thompson, Jeremy Tomlinson, Emmanuel A Tsochatzis, Andrew Yeoman, William Alazawi. Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group. The Lancet Gastroenterology & Hepatology 2022; 7(8) doi: 10.1016/S2468-1253(22)00061-9
|
| 82 |
Hilton Leao Filho, Virginia Goncalves, Nathalia Mendonca, Rafael Sachetin, Abdalla Skaf. Reproducibility of ROI methods and reliability of conventional versus chemical shift-encoded MRI for hepatic fat and iron quantification. Abdominal Radiology 2026; doi: 10.1007/s00261-026-05508-y
|
| 83 |
Fransina Ndevahoma, Munyaradzi Mukesi, Phiwayinkosi V. Dludla, Bongani B. Nkambule, Elina P. Nepolo, Tawanda M. Nyambuya. Body weight and its influence on hepcidin levels in patients with type 2 diabetes: A systematic review and meta-analysis of clinical studies. Heliyon 2021; 7(3) doi: 10.1016/j.heliyon.2021.e06429
|
| 84 |
Zhun Xiao, Minghao Liu, Fangming Yang, Guangwei Liu, Jiangkai Liu, Wenxia Zhao, Suping Ma, Zhongping Duan. Programmed cell death and lipid metabolism of macrophages in NAFLD. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1118449
|
| 85 |
Óscar Fonseca, Paulo J. Oliveira, Martina U. Muckenthaler, Ana C. Moreira, M. Salomé Gomes. Iron‐related intercellular communication in the liver: Main players and mechanisms. European Journal of Clinical Investigation 2026; 56(1) doi: 10.1111/eci.70168
|
| 86 |
. 2020; doi: 10.70675/d03e67aczc44bz4af9z8fa1zef080668f44f
|
| 87 |
Debabrata Dash, Raj Kumar Koiri, Jian Wu. Hepcidin–Ferroportin Axis, Gut Microbiota, and Ferroptosis Across Chronic Liver Diseases: Mechanistic Integration of an Iron Dysregulation Triad. Advanced Gut & Microbiome Research 2026; 2026(1) doi: 10.1155/agm3/3202391
|
| 88 |
Qunwei Ma, Daowen Zhang, Cancan Liu, Weiwei Zhu, Guixia Wang, Nannan Xu, Xue Zhang, Rui Huang, Huijun Zhang, Kuanlu Fan. Association between iron intake and risk of all-cause mortality in patients with nonalcoholic fatty liver disease: a retrospective study of NHANES. Human Nutrition & Metabolism 2026; 44 doi: 10.1016/j.hnm.2026.200365
|
| 89 |
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study. EBioMedicine 2019; 39 doi: 10.1016/j.ebiom.2018.11.020
|
| 90 |
Magdalena Ogłuszka, Paweł Lipiński, Rafał Radosław Starzyński. Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?. Critical Reviews in Food Science and Nutrition 2022; 62(11) doi: 10.1080/10408398.2020.1862047
|
| 91 |
Timothy J. Colgan, Ruiyang Zhao, Nathan T. Roberts, Diego Hernando, Scott B. Reeder. Limits of Fat Quantification in the Presence of Iron Overload. Journal of Magnetic Resonance Imaging 2021; 54(4) doi: 10.1002/jmri.27611
|
| 92 |
Diana Abu-Halaka, Adi Shpaizer, Haim Zeigerman, Joseph Kanner, Oren Tirosh. DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine. Antioxidants 2023; 12(2) doi: 10.3390/antiox12020512
|
| 93 |
Shunming Zhang, Yan Yan, Xu-Fen Zeng, Yeqing Gu, Hongmei Wu, Qing Zhang, Li Liu, Zhenyu Huo, Xiaoqin Luo, Rui Zhang, Emily Sonestedt, Yan Borné, Lu Qi, Tao Huang, Ming-Hua Zheng, Yu-Ming Chen, Kaijun Niu, Le Ma. Associations of the EAT-Lancet reference diet with metabolic dysfunction–associated steatotic liver disease and its severity: A multicohort study. Hepatology 2025; 81(5) doi: 10.1097/HEP.0000000000001039
|
| 94 |
Bilal Rah, Rumaisa Rafiq, Jasmine Sharafain, Jibran Sualeh Muhammad, Jalal Taneera, Mawieh Hamad. Modulation of hepcidin synthesis: the core link in the bi-directional relationship between iron and obesity. Reviews in Endocrine and Metabolic Disorders 2026; 27(1) doi: 10.1007/s11154-025-09997-y
|
| 95 |
Meryem KEÇELİ BAŞARAN, Okan GÜRKAN. Analysis of clinical findings and serum micronutrients in pediatric patients with nonalcoholic fatty liver disease. Journal of Health Sciences and Medicine 2023; 6(1) doi: 10.32322/jhsm.1190206
|
| 96 |
V. Nathan Subramaniam. Ironing out Steatohepatitis. Annals of Hepatology 2017; 16(1) doi: 10.5604/16652681.1226809
|
| 97 |
Kexin Sun, Jie V. Zhao, Edmund Anthony Severn Nelson, Vincent Wai Sun Wong, Hugh Simon Hung San Lam, Lai Ling Hui. Iron status and non-alcoholic fatty liver disease: A Mendelian randomization study. Nutrition 2024; 118 doi: 10.1016/j.nut.2023.112295
|
| 98 |
Liqun Wang, Xuxi Chen, Hongying Quan, Rui Qian, Shuyu Gong, Qiurong He, Ying Gao, Ajia Axi, Manyu Zhao, Qin Zhang, Ling Zhang, Lijun Peng, Xin Sun, Ben Zhang, Yuqin Yao. Macrophage–Derived Ferritin Exacerbates Silica‐Induced Pulmonary Fibrosis via PIK3R2‐Mediated Fibroblast Differentiation. Advanced Science 2026; 13(17) doi: 10.1002/advs.202519191
|
| 99 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Iron as a therapeutic target in chronic liver disease. World Journal of Gastroenterology 2023; 29(4): 616-655 doi: 10.3748/wjg.v29.i4.616
|
| 100 |
Octavia Pickett-Blakely, Kimberly Young, Rotonya M. Carr. Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2018; 6(4) doi: 10.1016/j.jcmgh.2018.07.004
|
| 101 |
Edouard Bardou-Jacquet, Houda Hamdi-Roze, Anita Paisant, Marie Decraecker, Marc Bourlière, Nathalie Ganne-Carrié, Victor de Lédinghen, Christophe Bureau. Non-invasive diagnosis and follow-up of hyperferritinaemia. Clinics and Research in Hepatology and Gastroenterology 2022; 46(1) doi: 10.1016/j.clinre.2021.101762
|
| 102 |
Muhammad Imran, Frédéric Chalmel, Odile Sergent, Bertrand Evrard, Hélène Le Mentec, Antoine Legrand, Aurélien Dupont, Maëlle Bescher, Simon Bucher, Bernard Fromenty, Laurence Huc, Lydie Sparfel, Dominique Lagadic-Gossmann, Normand Podechard. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. Cell Biology and Toxicology 2023; 39(2) doi: 10.1007/s10565-022-09706-4
|
| 103 |
Deepika Suresh, Ashley Li, Matthew J. Miller, Karn Wijarnpreecha, Vincent L. Chen. Associations between metabolic hyperferritinaemia, fibrosis‐promoting alleles and clinical outcomes in steatotic liver disease. Liver International 2024; 44(2) doi: 10.1111/liv.15787
|
| 104 |
Bertha Araceli Marin-Alejandre, Itziar Abete, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Iñigo Navarro-Blasco, Josep A. Tur, Narcisa M. Bandarra, M. Angeles Zulet, J. Alfredo Martinez. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study. Journal of Clinical Lipidology 2020; 14(6) doi: 10.1016/j.jacl.2020.08.007
|
| 105 |
Jianan Zhao, Yiyang Hu, Jinghua Peng. Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy. Cellular & Molecular Biology Letters 2021; 26(1) doi: 10.1186/s11658-021-00254-z
|
| 106 |
Wojciech Kupczyk, Joanna Boinska, Artur Słomka, Kinga Kupczyk, Marek Jackowski, Ewa Żekanowska. Estimation of New Regulators of Iron Metabolism in Short-Term Follow-Up After Bariatric Surgery. International Journal of Molecular Sciences 2025; 26(21) doi: 10.3390/ijms262110543
|
| 107 |
Faisal Alsaif, Waleed Al-hamoudi, Maram Alotaiby, Amani Alsadoon, Mohammed Almayouf, Hadeel Almadany, Jawahir Abuhaimed, Noman Ghufran, Ahmed Merajuddin, Imran Ali Khan. Molecular Screening via Sanger Sequencing of the Genetic Variants in Non-Alcoholic Fatty Liver Disease Subjects in the Saudi Population: A Hospital-Based Study. Metabolites 2022; 12(12) doi: 10.3390/metabo12121240
|
| 108 |
Hye Young Kim, Young Hyun Yoo. Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23168899
|
| 109 |
Kang Wang, Guilherme Moura Cunha, Kyle Hasenstab, Walter C. Henderson, Michael S. Middleton, Shelley A. Cole, Jason G. Umans, Tauqeer Ali, Albert Hsiao, Claude B. Sirlin. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data. American Journal of Roentgenology 2023; 221(5) doi: 10.2214/AJR.23.29607
|
| 110 |
Kendra A. Klag, Rickesha Bell, Xuan Jia, Alexandra Seguin, J. Alan Maschek, Mary Bronner, James E. Cox, June L. Round, Diane M. Ward. Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2. Nutrients 2024; 16(12) doi: 10.3390/nu16121804
|
| 111 |
Parker R. Johnson, Bryant H. Keirns, Gracie E. Meade, Parker A. Huizinga, Aiden Y. Kim, Riju Sigdel, Cameron J. Cardona, McKale R. Montgomery, Sam R. Emerson, Winyoo Chowanadisai. Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease incidence in metabolically healthy and unhealthy normal weight obesity. International Journal of Obesity 2026; doi: 10.1038/s41366-026-02133-z
|
| 112 |
Sander Lefere, Frank Tacke. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. JHEP Reports 2019; 1(1) doi: 10.1016/j.jhepr.2019.02.004
|
| 113 |
Xiaomin Wang, Xiaojing Zhang, Lin Ma, Shengli Li. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease. Science China Life Sciences 2018; 61(9) doi: 10.1007/s11427-017-9279-1
|
| 114 |
Anitha Pitchika, Jens‐Peter Kühn, Sabine Schipf, Matthias Nauck, Marcus Dörr, Markus M. Lerch, Marie‐Luise Kromrey, Stephan B. Felix, Marcello R. P. Markus, Wolfgang Rathmann, Henry Völzke, Till Ittermann. Hepatic steatosis and hepatic iron overload modify the association of iron markers with glucose metabolism disorders and metabolic syndrome. Liver International 2021; 41(8) doi: 10.1111/liv.14868
|
| 115 |
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASH. Nature Reviews Gastroenterology & Hepatology 2018; 15(6) doi: 10.1038/s41575-018-0009-6
|
| 116 |
Kosha J Mehta, Sebastien Je Farnaud, Paul A Sharp. Iron and liver fibrosis: Mechanistic and clinical aspects. World Journal of Gastroenterology 2019; 25(5): 521-538 doi: 10.3748/wjg.v25.i5.521
|
| 117 |
Ioannis Tsomidis, Angeliki Tsakou, Argyro Voumvouraki, Elias Kouroumalis. The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010151
|
| 118 |
Bin Cui, Hao Li, Rihua Cui, Xu Jiang, Xinglin Jin. Metabolic dysfunction–associated steatotic liver disease with alcohol- and iron overload–related cholestatic liver injury: a case report. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1805756
|
| 119 |
Fernando Moreto, Artur J. T. Ferron, Fabiane V. Francisqueti‐Ferron, Alfonsina D'Amato, Jessica L. Garcia, Mariane R. Costa, Carol Cristina V. A. Silva, Alessandra Altomare, Camila Renata Correa, Giancarlo Aldini, Ana Lucia A. Ferreira. Differentially expressed proteins obtained by label‐free quantitative proteomic analysis reveal affected biological processes and functions in Western diet‐induced steatohepatitis. Journal of Biochemical and Molecular Toxicology 2021; 35(6) doi: 10.1002/jbt.22751
|
| 120 |
Patrik Nasr, Simone Ignatova, Peter Lundberg, Stergios Kechagias, Mattias Ekstedt. Low hepatic manganese concentrations in patients with hepatic steatosis – A cohort study of copper, iron and manganese in liver biopsies. Journal of Trace Elements in Medicine and Biology 2021; 67 doi: 10.1016/j.jtemb.2021.126772
|
| 121 |
Hailang Li, Ling Hu, Liwen Wang, Yixuan Wang, Meiqi Shao, Yupei Chen, Wenlin Wu, Lei Wang. Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation. Journal of Agricultural and Food Chemistry 2022; 70(7) doi: 10.1021/acs.jafc.1c06681
|
| 122 |
James F. Collins, Shireen R.L. Flores, Xiaoyu Wang, Gregory J. Anderson. Physiology of the Gastrointestinal Tract. 2018; doi: 10.1016/B978-0-12-809954-4.00060-8
|
| 123 |
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
|
| 124 |
Yoshiharu Muto, Toshiro Moroishi, Kazuya Ichihara, Masaaki Nishiyama, Hideyuki Shimizu, Hidetoshi Eguchi, Kyoji Moriya, Kazuhiko Koike, Koshi Mimori, Masaki Mori, Yuta Katayama, Keiichi I. Nakayama. Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis. Journal of Experimental Medicine 2019; 216(4) doi: 10.1084/jem.20180900
|
| 125 |
Ning Li, Yilie Liao, Haipeng Huang, Suneng Fu. Co‐regulation of hepatic steatosis by ferritinophagy and unsaturated fatty acid supply. Hepatology Communications 2022; 6(10) doi: 10.1002/hep4.2040
|
| 126 |
Sharon Ntube Ngwese, Hassina Mouri, Richard Ayuk II Akoachere, Jennifer M. McKinley, Carla Candeias. Sources, Pathways, and Health Risk Assessment of Harmful Elements in Soil and Crops: A Case Study from East Cameroon. Exposure and Health 2025; 17(5) doi: 10.1007/s12403-025-00714-3
|
| 127 |
Baoqiang Zhu, Yuankui Wei, Mingming Zhang, Shiyu Yang, Rongsheng Tong, Wenyuan Li, Enwu Long. Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1286449
|